Revenue decreased 44.9%
Revenue changed -44.9% from the comparable as-filed period. The change ranks at the 87th percentile of 123 prior comparable changes.
$1.1B→$612.2M123 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CALY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue moved 2981 bp higher
Inventory / revenue changed +2981 basis points from the comparable as-filed period. The change ranks at the 99th percentile of 68 prior comparable changes.
54.83%→84.65%68 prior comparisons
Net income increased 270.4%
Net income changed +270.4% from the comparable as-filed period. The change ranks at the 86th percentile of 141 prior comparable changes.
$20.3M→$75.2M141 prior comparisons
Operating margin moved 922 bp higher
Operating margin changed +922 basis points from the comparable as-filed period. The change ranks at the 84th percentile of 123 prior comparable changes.
9.53%→18.75%123 prior comparisons
Debt decreased 99.5%
Debt changed -99.5% from the comparable as-filed period. The change ranks at the 75th percentile of 56 prior comparable changes.
$1.5B→$7.7M56 prior comparisons
Cash & equivalents decreased 59.3%
Cash & equivalents changed -59.3% from the comparable as-filed period. The change ranks at the 69th percentile of 216 prior comparable changes. This reverses 21 consecutive comparable moves in the opposite direction.
$683.5M→$278.1M216 prior comparisons
Selling, general & administrative decreased 27.2%
Selling, general & administrative changed -27.2% from the comparable as-filed period. The change ranks at the 71th percentile of 38 prior comparable changes.
$241.8M→$176.1M38 prior comparisons
Research & development decreased 20.2%
Research & development changed -20.2% from the comparable as-filed period. The change ranks at the 74th percentile of 123 prior comparable changes.
$19.8M→$15.8M123 prior comparisons
Operating income increased 8.5%
Operating income changed +8.5% from the comparable as-filed period. The change ranks at the 11th percentile of 123 prior comparable changes.
$105.8M→$114.8M123 prior comparisons
Inventory decreased 14.9%
Inventory changed -14.9% from the comparable as-filed period. The change ranks at the 39th percentile of 109 prior comparable changes.
$608.9M→$518.2M109 prior comparisons
Stock-based compensation decreased 14.3%
Stock-based compensation changed -14.3% from the comparable as-filed period. The change ranks at the 29th percentile of 119 prior comparable changes.
$7.0M→$6.0M119 prior comparisons
SBC / revenue moved 35 bp higher
SBC / revenue changed +35 basis points from the comparable as-filed period. The change ranks at the 69th percentile of 119 prior comparable changes.
0.63%→0.98%119 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.